Search Results - "Lang, Teresa R"

Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism by Wysokinski, Waldemar E., Houghton, Damon E., Vlazny, Danielle T., Ashrani, Aneel A., Froehling, David A., Kamath, Patrick S., Meverden, Ryan A., Hodge, David O., Peterson, Lisa G., Lang, Teresa R., McBane, Robert D., Casanegra, Ana I.

“…The outcome of anticoagulation for cancer-associated venous thromboembolism (Ca-VTE) differs according to cancer location, but data are limited and…”
Get full text

Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism by Bott-Kitslaar, Dalene M., McBane, Robert D., Casanegra, Ana I., Houghton, Damon E., Froehling, David A., Vlazny, Danielle T., Ashrani, Aneel A., Hodge, David O., Vargas, Emily R., Bartlett, Matthew A., Saadiq, Rayya A., Daniels, Paul R., Shields, Raymond C., Lenz, Charles J., Lang, Teresa R., Wysokinski, Waldemar E.

“…To compare the clinical efficacy and safety of apixaban with those of rivaroxaban for the treatment of acute venous thromboembolism (VTE). Consecutive patients…”
Get full text

Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin by Houghton, Damon E., Bott-Kitslaar, Dalene M., Vargas, Emily, Hodge, David O., Lang, Teresa R, Peterson, Lisa, Casanegra, Ana I, McBane, Robert D., Wysokinski, Waldemar E., Froehling, David A

“…Background: Randomized control trials (RCT) have examined the safety and efficacy of direct oral anticoagulants (DOACs) compared to dalteparin in patients with…”
Get full text